Brief: Alk Abello announces MITICURE available in Japan
Nov 26 (Reuters) - Alk Abello A/S ALKb.CO :
* MITICURE has been placed on Japanese National Health Insurance reimbursement list and will
be launched in beginning of December
* Drug will be available for prescription in Japan for adults and adolescents (12-64 years)
who suffer from house dust mite allergic rhinitis
Source text for Eikon: ID:nGNXVEWPRa
Further company coverage: ALKb.CO
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)